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Material and Methods: Based on qualitative meta-synthesis 
as described by Sandelowski and Barroso four research 
articles were systematically identified and included in the 
study. Only studies conducted in the Scandinavian countries 
were included to ensure a similar cultural context and 
organization of the health care system. The meta-synthesis 
was conducted in a hermeneutic perspective, and consisted 
of five phases; search phase, appraisal phase, classification 
phase, analysis phase and synthesis phase. The synthesis 
phase was complemented by the approach imported concepts 
to expand comprehension and integrate the findings. 
 
Results: The results suggest that the experience of 
radiotherapy is described by the main theme: The 
importance of being greeted as a human being and six sub-
themes; The role and competence of the RTT; Continuity and 
relationships; Isolation; High-tech environment; Active 
participation and Knowledge and guidance.The main theme 
and sub-themes are illustrated in Figure 1. 
 
Figure 1  
The results are integrated with notions on care by Kari 
Martinsen with reference to the Danish philosopher 
Loegstrup, suggesting that the RTTs must be very aware of 
their role in the encounter with the individual; including 
being responsible for building trust and protecting the 
continuity in the relationship. The results suggest that 
structural issues in the health care system, such as efficacy 
and task prioritization, can jeopardize the relationship and 
communication between the RTT and the patient. 
 
Conclusion: The results of the study provide evidence to 
work more actively with ensuring continuity during the 
radiotherapy trajectory to provide a higher level of care and 
communication with the individual patient. In addition, the 
study introduces an increased awareness amongst RTTs 
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Purpose or Objective: Deep inspiration breath hold (DIBH) 
for breast boost requires photons due to the limitations of 
the Varian RPM DIBH monitoring equipment, precluding the 
use of electrons. Traditionally, an electron boost was felt to 
be superior compared to photons due to their rapid dose fall 
off and resultant low dose to the heart and short treatment 
time. If an electron boost was deemed superior, this would 
need to be delivered with the patient free breathing (FB) due 
to aforementioned limitations. The primary aim of this study 
is to compare photons at DIBH to electron boost at FB with 
regards to plan quality and organ at risk (OAR) constraints to 
the heart and lungs in left sided breast patients. The 
secondary aim was to assess if the dosimetric detriment of 
the inferior modality would detract from the benefits gained 
in Phase 1, whole breast DIBH treatment. 
 
Material and Methods: Twenty consecutive patients 
undergoing radiotherapy to the left breast with DIBH were 
identified. All patients underwent dual CT scans at DIBH and 
FB as per the standard departmental protocol. A boost 
treatment was retrospectively planned with electrons on the 
FB scan and photons on a DIBH scan to a prescription on 10Gy 
in 5 fractions. PTV coverage, mean and maximum, doses to 
the heart and left anterior descending artery (LAD) and mean 
doses to the lungs were compared. The results were further 
analysed by the location of the boost volume as defined by 
breast quadrants. 
 
Results: Doses to the planning target volume (PTV) and mean 
heart doses were comparable between photons and 
electrons. Maximum heart doses reduced by 60% while 
maximum and mean LAD doses reduced by 54% and 51.2% 
respectively using photons, while mean left lung dose 
reduced by 43%. These reductions were seen across all four 
breast quadrants.  
When combined with the reductions in doses seen using DIBH 
for Phase 1, whole breast treatment, electrons would result 
in an overall treatment dose increase of 11% for the heart 
maximum, 7.3% and 14% for LAD mean and maximum 
respectively and 70% for lung mean. 
 
Conclusion: Dosimetrically photons was a superior modality 
when compared to electrons in phase 2 Left breast treatment 
maintaining benefits to the heart and lung gained through 
DIBH without compromising PTV coverage. The results were 
applicable regardless of the location of the boost volume. 
The increase in mean lung, maximum heart and maximum 
and mean LAD doses would negatively impact on the 
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Purpose or Objective: To analyse the pattern of recurrence 
and acute and late toxicity of 105 patients treated with 
Stupp protocol in relation to both radiotherapy technique 
(3D, IMRT and helical IMRT) and treatment volumes; to 
compare in silico plans with reduced GTV-CTV margin (1 cm) 
with the original ones (2 cm). The CTV-PTV margin (5 mm) 
was maintained. 
 
Material and Methods: Relapse was considered as in field, 
marginal and distant if more than 80%, 20-80% or <20% of the 
relapse volume was included respectively in the 95% isodose. 
In silico plans with reduced margin were retrospectively re-
calculated using exactly the same technique, the same fields 
angles and, if possible, the same TPS of the original plans. 
Statistical analysis was performed with SPSS® software. 
 
Results: Eighty-five patients had local recurrence: 3 were 
excluded because underwent follow-up MRI in other 
hospitals; 14 because the original treatment plans were not 
recoverable. The analysis was therefore executed on 68 
patients. They were in field, marginal and distant 
respectively in 88%, 10% and 2% of the cases. This pattern of 
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relapse was similar (pt student= ns) when the analysis was 
done on the in silico plans. The margins reduction appears to 
avoid the inclusion in the high dose volume of about 100 cc of 
healthy brain (p=0.02) (Table 1). The target coverage was 
significantly worse in original than in the in silico plans (pt 
student <0.001) (Table 1), especially if the tumour was close 
to organs at risk (pχ2 <0.001). PTV coverage of original plans 
was significantly better with IMRT and helical-IMRT when 
compared with 3D ones (pAnova test=0.038). This difference 
was no more statistically significant with in silico planning 
(pAnova test= n.s.). Higher incidence of asthenia and leuko-
encephalopathy was observed in patients with greater 
percentage of healthy brain included in the 57 Gy isodose 




Conclusion: No differences in the pattern of recurrence 
according to the extent of margins have been found. The 
incidence of asthenia and leuko-encephalopaty varies with 
the percentage of healthy brain included in the high dose 
volume. The margin reduction allows significant sparing of 
healthy cerebral tissue and could possibly reduce the 
incidence of late toxicity. Margin reduction is compatible 
with appropriate target coverage, thereby limiting the need 
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Purpose or Objective: Elderly patients with lung cancer are 
often referred to treatment with radiotherapy. Tolerance to 
treatment and survival may be determined by their age and 
performance status. Different fractionation schedules in 
these patients can also influence the results. 
Our objective was to analyze survival in patients ≥70years, 
depending on age groups, Karnofsky Status (KPS) and 
fractionation schemes. 
 
Material and Methods: We analyzed 70 patients, aged ≥70 
years, with diagnostic of lung tumors (T1-4; N1-3), with no 
previous surgery treatments, referred for external 
radiotherapy.  
Total Dose range: 20-64Gy; fractionation schedules: 1.8-2Gy 
(considered standard, std), >2Gy 
(hypofractionation/stereotactic SBRT) Karnofsky Performance 
Status (KPS), was the tool to evaluate functional status the 
first day of treatment, and analysis was performed with two 
KPS groups: <70 vs ≥ 70 
 
 
Results: Global survival: mean 9months (m); median 8 m.  
12m survival: 22patients (31,4%)  
18m survival: 8pts (11,4%)  
>23m survival: 4pts (5,7%)  
AGE: 
70-79y: mean 9m; median 8 m  
≥80y: mean: 9,2m; median: 8 m  
KARNOFSKY PERFORMANCE STATUS (KPS) 
Survival:  
KPS <70: mean: 9,2m; median: 8  
KPS ≥70: mean: 9m; median: 8  
FRACTIONATION SCHEDULE:  
standard fx: 29 pts mean:9.2m; median: 8  
hypofractionation: 34pts mean: 8m; median: 7 m  
only SBRT: 7pts mean: 9.7m; median: 8.5m  
fractionation survival:  
≥6months: std: 20 pts (67%) hypofx: 19 (56%)  
≥12m: std: 11pts (38%) hypofx: 9pts (26.4%)  
≥18m: std: 5 pts (17.2%) hypofx: 2 pts (0,6%) 
 
Conclusion: In elderly patients the most advanced age (> 80 
years) does not determine differences in survival after 
radiotherapy treatment.  
There are no differences in survival of elderly patients 
according to the KPS (<70 vs ≥70)  
Survival is very similar regardless of the fractionation scheme 
used (mean 9.2 vs 8 months). However, 6, 12 and 18 months 
survival is greater in patients with standard fractionation We 
can conclude that in elderly patients, the variables age, KPS 
or fractionation scheme does not determine significant 
differences in survival.  
Hypofractionation techniques or SBRT should be considered 
as an alternative in frail elderly patients to avoid prolonged 
treatment in time. The analysis of other parameters such as 
tumor stage or additional chemotherapy could also 
discriminate populations with different prognostic. 
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Purpose or Objective: A baseline shift can be defined as a 
shift of the target volume relative to its surrounding organs 
at risk (OAR). The baseline shift varies from day to day and 
can potentially lead to an overdosage of the OARs. In our 
clinic, the magnitude of the baseline shift is measured at the 
start of treatment in patients treated for solitary lung 
cancer. In case an OAR moves towards the target and the 
baseline shift exceeds the PRV margin, treatment is 
prevented. Limited data is available about the intra-
fractional change of the baseline shift. The aim of this study 
is to determine if an intra-fractional change of the baseline 
shift necessitates multiple measurements to ensure safe 
delivery of SBRT. 
 
Material and Methods: In this study a retrospective analysis 
was performed using the data of 87 patients, treated for lung 
cancer with SBRT in the period January 2010 to February 
2014. Patients were treated according to one of three 
protocols: 3x18Gy (n=19), 5x11Gy (n=47), or 8x7.5Gy (n=21). 
Treatment delivery was performed using multiple (> 9) non-
coplanar conformal beams or VMAT using 2 arcs. A planning 
risk volume (PRV) margin of 10mm was used standard around 
OARs (e.g. the heart and spinal cord). Smaller PRV margins, 
with a minimum of 3mm, were used in case 
prescriptions/constraints could not be met during planning.  
Conebeam-CT scans were performed at the beginning, 
halfway, and at the end of each treatment fraction. Grey-
value registrations of Conebeam-CT scans with Planning-CT 
scan were performed for both the target and the patient 
specific most critical OAR . The difference between the 
registrations is the baseline shift. The number of times the 
